Hosted by the Biotechnology Market Organization.

– 3:30 p.m. Speakers Include: Jens Oliver Funk, M.D., EMD Serono, Inc.; Wayne Godfrey, BN ImmunoTherapeutics, Inc.; Jeffrey Schlom, Ph.D., National Tumor Institute; Helen Sabzevari, National Cancer Institute; Mark Frohlich, M.D., Dendreon Commercialization of Biomarkers: From Discovery to Medical Diagnostics Monday, May 3, 4:00 p.m. – 5:30 p.m. Speakers include: Tim Clark, Piper Alderman; Christopher Boyle, Bio-Link; Michael Henry, Athena Diagnostics Build or Buy? Strategic Options in Biomanufacturing Tuesday, May 4, 2:00 p.m. – 3:30 p.m. Audio speakers Consist of: Anne Montgomery, BioProcess International; Laura Bush, Advanstar Communications; Parrish Galliher, M.S., Xcellerex, Inc; Steven Lee, Ph.D., A-Bio Pharma Pte Ltd.; Alain Pralong, Crucell NV; Eric Langer, Ph.D., BioPlan Associates, Inc.m.In the future, the team envisions a range of nanodiamond-silk structures that may help researchers improve techniques for fighting attacks in targeted areas of the body. A slim film of the new substance, carrying medications, could be implanted straight into an infected area, minimizing the patient’s exposure to the drugs. Silk can also be made to degrade at a certain rate, which would allow clinicians to control the release of medicines. In addition to the University of Melbourne, the experts are affiliated with the University of Sydney and the Silk Laboratory at Tufts University in Massachusetts.